` 688739 (Liaoning Chengda Biotechnology Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

688739
vs
S
Shanghai Composite

Over the past 12 months, Liaoning Chengda Biotechnology Co Ltd has underperformed Shanghai Composite, delivering a return of +1% compared to the Shanghai Composite's +28% growth.

Stocks Performance
688739 vs Shanghai Composite

Loading
688739
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688739 vs Shanghai Composite

Loading
688739
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
688739 vs Shanghai Composite

Loading
688739
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Liaoning Chengda Biotechnology Co Ltd vs Peers

Shanghai Composite
688739
RYI
AVGR
BROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Liaoning Chengda Biotechnology Co Ltd
Glance View

Market Cap
10.9B CNY
Industry
Biotechnology

Liaoning Chengda Biotechnology Co., Ltd. is engaged in the research, development, manufacture and sale of vaccines. The company is headquartered in Shenyang, Liaoning and currently employs 1,663 full-time employees. The company went IPO on 2021-10-28. The firm's main products include rabies vaccine for human use, freeze-dried rabies vaccine for human use, inactivated Japanese encephalitis vaccine for human use and freeze-dried encephalitis inactivated vaccine. The firm's products include two brands: Chengda Suda and Chengda Libao.

Intrinsic Value
20.4 CNY
Overvaluation 22%
Intrinsic Value
Price
Back to Top